BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7662572)

  • 1. Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.
    Panidis D; Skiadopoulos S; Rousso D; Ioannides D; Panidou E
    Br J Dermatol; 1995 Jun; 132(6):936-41. PubMed ID: 7662572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.
    Conway GS; Jacobs HS
    Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
    Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
    Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
    Bhattacharya SM
    Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
    Taketani Y; Mizuno M
    Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.
    Reyes-Muñoz E; Ortega-González C; Martínez-Cruz N; Arce-Sánchez L; Estrada-Gutierrez G; Moran C; Sánchez-Serrano AP; Higareda-Sánchez R; de la Jara-Díaz JF
    BMJ Open; 2016 Jul; 6(7):e012107. PubMed ID: 27449893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans.
    Farah MJ; Givens JR; Kitabchi AE
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1075-81. PubMed ID: 2138630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.